Skip to main content
. 2020 Dec 21;3(1):100049. doi: 10.1016/j.cytox.2020.100049

Table 1.

CRISPR-tools.

Type Advantages Disadvantages Applied in primary T cells Ref
Lentiviral Inclusion of selection marker Low knock-out efficacy
Genomic integration
Yes [76], [77]
Electroporation T cells retain expansion potential
Extensive protocols are available
Cytotoxic Costly Yes [48], [73], [89], [90], [91]
(Lipid) nanoparticles Highly adaptable to specific need Complex to engineer No [84], [85]
Ligand fusion tags Cell-type specific Cells need to express receptor No [83]
Cell-penetrating peptides Produced in-house Varying quality and efficacy due to batch-to-batch differences No [86], [87], [88]